|
Market Cap | 12.82B | EPS (ttm) | 4.96 |
P/E | 60.47 | EPS this Y | 37.46% |
Forward P/E | 36.32 | EPS next Y | 17.28% |
PEG | 3.78 | EPS past 5Y | -5.02% |
P/S | 6.04 | EPS next 5Y | 16.00% |
P/B | 9.26 | EPS Q/Q | 935.01% |
Dividend | 0.59% | Sales Q/Q | 11.11% |
Insider Own | 37.23% | Inst Own | 60.50% |
Insider Trans | -1.89% | Inst Trans | 0.42% |
Short Float | 0.67% | Earnings | Apr 24/a |
Analyst Recom | 1.00 | Target Price | 340.00 |
Avg Volume | 120.53K | 52W Range | 185.15 - 316.05 |
|
|
|
Morningstar, Inc. engages in the provision of investment research. It offers Morningstar data, direct, investment management, advisor workstation, workplace solutions, pitchbook data, enterprise components, research, credit ratings and indexes. The company was founded by Joseph D. Mansueto on May 16, 1984, and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Dunn Daniel Joseph | Chief Revenue Officer | May 17 '24 | Option Exercise | 0.00 | 697 | 0 | 15,269 | May 17 08:19 PM | DUBINSKY JASON | Chief Financial Officer | May 17 '24 | Option Exercise | 0.00 | 1,254 | 0 | 24,792 | May 17 08:22 PM | Kapoor Kunal | CEO | May 17 '24 | Option Exercise | 0.00 | 5,580 | 0 | 138,523 | May 17 08:22 PM | Mansueto Joseph D | Executive Chairman | May 16 '24 | Sale | 300.61 | 6,062 | 1,822,319 | 10,697,450 | May 17 08:24 PM | Mansueto Joseph D | Executive Chairman | May 15 '24 | Sale | 301.10 | 4,804 | 1,446,501 | 10,703,512 | May 17 08:24 PM |
|
|
|
|
Market Cap | 139.32M | EPS (ttm) | -0.61 |
P/E | - | EPS this Y | -5.30% |
Forward P/E | - | EPS next Y | 26.68% |
PEG | - | EPS past 5Y | 18.22% |
P/S | 1.10 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 51.42% |
Dividend | - | Sales Q/Q | 100.00% |
Insider Own | 20.91% | Inst Own | 41.50% |
Insider Trans | -0.14% | Inst Trans | 12.84% |
Short Float | 17.92% | Earnings | May 08/b |
Analyst Recom | 1.86 | Target Price | 6.20 |
Avg Volume | 5.01M | 52W Range | 0.54 - 6.26 |
|
|
|
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shaff Eric D. | CEO and President | May 15 '24 | Sale | 0.94 | 2,435 | 2,289 | 140,698 | May 17 08:18 PM | Ege David S. | See Remarks | May 15 '24 | Sale | 0.94 | 1,090 | 1,025 | 75,734 | May 17 08:16 PM | von Moltke Lisa | See Remarks | May 15 '24 | Sale | 0.94 | 939 | 883 | 19,017 | May 17 08:23 PM | Henn Matthew R. | See Remarks | May 15 '24 | Sale | 0.94 | 891 | 838 | 65,357 | May 17 08:17 PM | DesRosier Thomas | Chief Legal Officer and EVP | May 15 '24 | Sale | 0.94 | 843 | 792 | 122,390 | May 17 08:14 PM |
|
|
|
|
Market Cap | 1.17B | EPS (ttm) | 0.01 |
P/E | 3921.05 | EPS this Y | 15.11% |
Forward P/E | 20.21 | EPS next Y | 15.42% |
PEG | - | EPS past 5Y | 0.83% |
P/S | 4.58 | EPS next 5Y | - |
P/B | 8.57 | EPS Q/Q | 95.97% |
Dividend | - | Sales Q/Q | 4.00% |
Insider Own | 7.18% | Inst Own | 91.88% |
Insider Trans | -5.96% | Inst Trans | 0.53% |
Short Float | 10.30% | Earnings | May 06/b |
Analyst Recom | 3.00 | Target Price | 30.00 |
Avg Volume | 745.75K | 52W Range | 20.90 - 35.96 |
|
|
|
Model N, Inc. engages in developing and monetizing revenue management solutions. It offers cloud revenue optimization and compliance to pharmaceutical, medical technology, semiconductor, and high-tech companies. Its products provide business processes such as pricing, quoting, contracting, regulatory compliance, rebates and incentives. The company was founded by Yarden Malka, Zack Rinat, and Ali Tore on December 14, 1999 and is headquartered in San Mateo, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Blessing Jason | Chief Executive Officer | May 16 '24 | Sale | 29.79 | 20,179 | 601,132 | 884,172 | May 17 08:19 PM | Ederer John | Chief Financial Officer | May 16 '24 | Sale | 29.79 | 10,741 | 319,974 | 296,386 | May 17 08:19 PM | Lyon Christopher | Chief Revenue Officer | May 16 '24 | Sale | 29.79 | 8,786 | 261,735 | 220,935 | May 17 08:20 PM | Kannan Suresh | Chief Product Officer | May 16 '24 | Sale | 29.79 | 8,685 | 258,726 | 250,920 | May 17 08:18 PM | Rayani Rehmann | Chief Strategy & Mktg Officer | May 16 '24 | Sale | 29.79 | 7,367 | 219,463 | 129,599 | May 17 08:19 PM |
|
|
| |
|
Market Cap | 1197.02B | EPS (ttm) | 17.41 |
P/E | 27.11 | EPS this Y | 35.99% |
Forward P/E | 20.36 | EPS next Y | 14.62% |
PEG | 0.90 | EPS past 5Y | 14.46% |
P/S | 8.39 | EPS next 5Y | 30.00% |
P/B | 8.01 | EPS Q/Q | 114.26% |
Dividend | 0.39% | Sales Q/Q | 27.26% |
Insider Own | 13.88% | Inst Own | 67.83% |
Insider Trans | -1.37% | Inst Trans | -1.63% |
Short Float | 1.29% | Earnings | Apr 24/a |
Analyst Recom | 1.47 | Target Price | 521.76 |
Avg Volume | 16.26M | 52W Range | 238.14 - 531.49 |
|
|
|
Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LI SUSAN J | Chief Financial Officer | May 16 '24 | Sale | 475.71 | 18,643 | 8,868,744 | 69,757 | May 17 08:12 PM | Bosworth Andrew | Chief Technology Officer | May 16 '24 | Sale | 475.76 | 14,745 | 7,015,082 | 6,848 | May 17 08:12 PM | Clegg Nicholas | President, Global Affairs | May 16 '24 | Sale | 475.74 | 7,290 | 3,468,121 | 7,528 | May 17 08:14 PM | Newstead Jennifer | Chief Legal Officer | May 16 '24 | Sale | 475.00 | 905 | 429,875 | 44,180 | May 17 08:09 PM | Olivan Javier | Chief Operating Officer | May 16 '24 | Sale | 475.00 | 618 | 293,550 | 15,788 | May 17 08:14 PM |
|
|
|
|
Market Cap | 614.70M | EPS (ttm) | -1.08 |
P/E | - | EPS this Y | 15.66% |
Forward P/E | - | EPS next Y | 17.67% |
PEG | - | EPS past 5Y | 12.47% |
P/S | 4.27 | EPS next 5Y | 8.90% |
P/B | 3.70 | EPS Q/Q | 16.38% |
Dividend | - | Sales Q/Q | 15.77% |
Insider Own | 9.88% | Inst Own | 91.87% |
Insider Trans | -2.69% | Inst Trans | -0.55% |
Short Float | 7.60% | Earnings | May 06/a |
Analyst Recom | 1.00 | Target Price | 25.56 |
Avg Volume | 469.71K | 52W Range | 13.96 - 29.51 |
|
|
|
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
RECUPERO ANTHONY J | President, Commercial Ops | May 17 '24 | Sale | 14.84 | 2,068 | 30,692 | 246,938 | May 17 08:08 PM | RECUPERO ANTHONY J | President, Commercial Ops | May 16 '24 | Sale | 15.10 | 3,941 | 59,502 | 247,592 | May 17 08:08 PM | Maheshwari Anshul | Chief Financial Officer | May 16 '24 | Sale | 15.14 | 2,441 | 36,954 | 204,241 | May 17 08:06 PM | DUNN JEFFREY W | Director | May 16 '24 | Sale | 15.13 | 1,581 | 23,922 | 21,512 | May 17 08:05 PM | DUNN JEFFREY W | Director | May 02 '24 | Sale | 14.54 | 343 | 4,986 | 23,566 | May 02 04:32 PM |
|
|
| |
|
Market Cap | 4.83B | EPS (ttm) | 3.76 |
P/E | 29.58 | EPS this Y | 12.96% |
Forward P/E | 28.56 | EPS next Y | 15.71% |
PEG | 2.96 | EPS past 5Y | 118.73% |
P/S | 5.75 | EPS next 5Y | 10.00% |
P/B | 17.42 | EPS Q/Q | 386.86% |
Dividend | - | Sales Q/Q | 9.74% |
Insider Own | 1.89% | Inst Own | 97.20% |
Insider Trans | -14.06% | Inst Trans | -1.35% |
Short Float | 1.90% | Earnings | Apr 30/b |
Analyst Recom | 2.11 | Target Price | 118.00 |
Avg Volume | 308.20K | 52W Range | 63.00 - 113.37 |
|
|
|
Commvault Systems, Inc. engages in the provision of data protection, information management software applications, and related services. The firm offers platform, solution packages, use cases, and workloads. It operates through the United States and Other geographical segments. The company was founded in 1996 and is headquartered in Tinton Falls, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mirchandani Sanjay | President & CEO | May 17 '24 | Sale | 110.85 | 30,108 | 3,337,524 | 522,312 | May 17 08:02 PM | Merrill Gary | Chief Financial Officer | May 17 '24 | Sale | 110.87 | 8,402 | 931,499 | 122,324 | May 17 08:01 PM | Mirchandani Sanjay | President & CEO | May 16 '24 | Sale | 110.20 | 15,975 | 1,760,445 | 539,465 | May 17 08:02 PM | Merrill Gary | Chief Financial Officer | May 16 '24 | Sale | 110.20 | 6,040 | 665,608 | 128,207 | May 17 08:01 PM | Lee Vivie | Director | May 16 '24 | Sale | 112.19 | 2,500 | 280,475 | 13,589 | May 17 08:02 PM |
|
|
|
|
Market Cap | 1.55B | EPS (ttm) | 5.32 |
P/E | 16.18 | EPS this Y | -23.81% |
Forward P/E | 15.52 | EPS next Y | 19.47% |
PEG | 0.81 | EPS past 5Y | -13.18% |
P/S | 13.06 | EPS next 5Y | 20.00% |
P/B | 1.91 | EPS Q/Q | 103.66% |
Dividend | - | Sales Q/Q | -29.56% |
Insider Own | 2.30% | Inst Own | 93.49% |
Insider Trans | -9.60% | Inst Trans | -0.32% |
Short Float | 4.53% | Earnings | May 07/a |
Analyst Recom | 1.20 | Target Price | 116.80 |
Avg Volume | 188.32K | 52W Range | 49.24 - 94.57 |
|
|
|
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Espinoza Octavio | Chief Financial Officer | May 17 '24 | Option Exercise | 55.71 | 6,917 | 385,346 | 28,535 | May 17 07:59 PM | Espinoza Octavio | Chief Financial Officer | May 17 '24 | Sale | 86.66 | 5,156 | 446,844 | 23,379 | May 17 07:59 PM | Espinoza Octavio | Chief Financial Officer | May 16 '24 | Sale | 86.00 | 2,264 | 194,712 | 21,618 | May 17 07:59 PM | Espinoza Octavio | Chief Financial Officer | May 15 '24 | Sale | 86.01 | 5,873 | 505,148 | 23,882 | May 17 07:59 PM | Korenberg Matthew E | President & Chief Operating | May 14 '24 | Sale | 85.10 | 14,158 | 1,204,912 | 86,263 | May 15 07:34 PM |
|
|
| |
|
Market Cap | 3.16B | EPS (ttm) | -0.01 |
P/E | - | EPS this Y | 4.55% |
Forward P/E | 38.94 | EPS next Y | 22.98% |
PEG | - | EPS past 5Y | -15.14% |
P/S | 2.92 | EPS next 5Y | 2.00% |
P/B | 2.42 | EPS Q/Q | 116.85% |
Dividend | - | Sales Q/Q | 19.59% |
Insider Own | 2.43% | Inst Own | 86.33% |
Insider Trans | -3.44% | Inst Trans | -2.55% |
Short Float | 2.15% | Earnings | May 07/a |
Analyst Recom | 1.64 | Target Price | 22.91 |
Avg Volume | 1.47M | 52W Range | 12.88 - 21.60 |
|
|
|
Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Carrai Phillip D | President, STC Division | May 15 '24 | Sale | 20.19 | 3,500 | 70,669 | 286,587 | May 17 07:48 PM | Mendoza Marie | SVP & General Counsel | May 15 '24 | Sale | 20.20 | 1,500 | 30,295 | 65,515 | May 17 07:57 PM | Lund Deanna H | EVP & CFO | May 08 '24 | Sale | 20.00 | 6,000 | 120,000 | 310,001 | May 10 05:48 PM | Fendley Steven S. | President, US Division | Apr 29 '24 | Sale | 18.76 | 7,000 | 131,300 | 423,098 | May 01 07:43 PM | Carrai Phillip D | President, STC Division | Apr 15 '24 | Sale | 18.19 | 3,500 | 63,652 | 290,118 | Apr 17 07:50 PM |
|
|
|
|
Market Cap | 2.80B | EPS (ttm) | -1.36 |
P/E | - | EPS this Y | 225.98% |
Forward P/E | 26.35 | EPS next Y | 271.48% |
PEG | - | EPS past 5Y | 22.66% |
P/S | 2.16 | EPS next 5Y | - |
P/B | 6.00 | EPS Q/Q | 26.34% |
Dividend | - | Sales Q/Q | -14.50% |
Insider Own | 15.00% | Inst Own | 75.95% |
Insider Trans | -0.44% | Inst Trans | 10.74% |
Short Float | 20.08% | Earnings | May 09/a |
Analyst Recom | 2.12 | Target Price | 16.36 |
Avg Volume | 5.79M | 52W Range | 8.41 - 18.76 |
|
|
|
Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
SODERBERG SHAWN MARIE | See Remarks | May 16 '24 | Sale | 12.17 | 1,160 | 14,117 | 166,843 | May 17 07:56 PM | ZERVIGON EDDY | Director | May 15 '24 | Sale | 12.86 | 28,150 | 362,009 | 111,161 | May 17 07:24 PM | Sridhar KR | Chairman & CEO | May 13 '24 | Sale | 11.93 | 40,112 | 478,536 | 2,742,496 | May 14 08:03 PM | Sridhar KR | Chairman & CEO | May 12 '24 | Option Exercise | 0.00 | 80,000 | 0 | 2,782,608 | May 14 08:03 PM | SODERBERG SHAWN MARIE | See Remarks | Apr 16 '24 | Sale | 9.86 | 8,963 | 88,375 | 168,003 | Apr 17 05:00 PM |
|
|
|
|
Market Cap | 63.62M | EPS (ttm) | -3.74 |
P/E | - | EPS this Y | -0.45% |
Forward P/E | - | EPS next Y | -1.84% |
PEG | - | EPS past 5Y | 39.98% |
P/S | - | EPS next 5Y | - |
P/B | 0.60 | EPS Q/Q | -21.41% |
Dividend | - | Sales Q/Q | - |
Insider Own | 19.88% | Inst Own | 39.29% |
Insider Trans | -5.83% | Inst Trans | -2.32% |
Short Float | 6.25% | Earnings | May 02/b |
Analyst Recom | 1.00 | Target Price | 27.80 |
Avg Volume | 361.65K | 52W Range | 1.04 - 5.24 |
|
|
|
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Opaleye Management Inc. | 10% Owner | May 17 '24 | Sale | 3.25 | 70,885 | 230,326 | 126,050 | May 17 07:48 PM | Opaleye Management Inc. | 10% Owner | May 10 '24 | Sale | 3.11 | 151,700 | 472,424 | 2,380,294 | May 10 06:57 PM | Opaleye Management Inc. | 10% Owner | May 09 '24 | Sale | 3.09 | 30,600 | 94,526 | 2,531,994 | May 10 06:57 PM |
|
|
|